Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer

Authors and Affiliations

1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

   Toni K. Choueiri & Bradley A. McGregor

2. University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA

   Jaime Merchán

3. The START Center for Cancer Research, San Antonio, TX, USA

   Amita Patnaik

4. Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA

   Alexandra Drakaki

5. Vanderbilt-Ingram Cancer Center, Nashville, TN, USA

   Brian I. Rini

6. Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea

   Sun Young Rha

7. Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

   Jae Lyun Lee

8. Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA

   Moshe C. Ornstein

9. Division of Hematology Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA

   Rohit Kumar

10. Department of Internal Medicine, Henry Ford Health System, Henry Ford Cancer Institute, Detroit, MI, USA

    Clara Hwang

11. Karmanos Cancer Center, Detroit, MI, USA

    Yusra Shao

12. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    Se Hoon Park

13. University Hospitals Seidman Cancer Center, Cleveland, OH, USA

    Pedro C. Barata

14. Arcus Biosciences, Inc., Hayward, CA, USA

    Paul Foster, Jianfen Chen, Melissa Eisen, Hunter Cole, Ben Weeder, Yinghui Guan, Jaskirat Singh, Angelo Kaplan, Soonweng Cho, Richard Markus & Omar Kabbarah

15. Division of Hematology Oncology, University of California, San Diego, San Diego, CA, USA

    Rana R. McKay

Corresponding author

Correspondence to Toni K. Choueiri.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions